The Effect of Varenicline on D2/D3 Receptor Binding in Smokers

NACompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

September 30, 2012

Primary Completion Date

August 31, 2015

Study Completion Date

August 31, 2015

Conditions
Nicotine Dependence
Interventions
DRUG

Varenicline

Varenicline will be administered as prescribed: 0.5 mg for the first 3 days then 1 mg for the next 7 days and 2 mg after that. A quit date will be chosen at 11 days after starting Varenicline. Varenicline will be given for 3 months.

Trial Locations (1)

Unknown

Centre for Addiction and Mental Health, Toronto

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Ontario Lung Association

OTHER

collaborator

Pfizer

INDUSTRY

lead

Centre for Addiction and Mental Health

OTHER

NCT01632189 - The Effect of Varenicline on D2/D3 Receptor Binding in Smokers | Biotech Hunter | Biotech Hunter